NCT06915025 2026-02-27
OVATION-3
Imunon
Phase 3 Recruiting
Clinical Trials
5 trialsNCT05335993 2025-07-10
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
CanariaBio Inc.
Phase 2 Active not recruiting
NCT05187208 2022-01-26
POLO
Seoul National University Hospital
Phase 4 Unknown
NCT04546373 2021-08-05
Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
Grupo Español de Investigación en Cáncer de Ovario
Completed
NCT04986371 2021-08-02
RENI-1
ChineseAMS
Unknown